Background Autologous stem cell transplant (ASCT) is an established treatment for patients
with newly diagnosed multiple myeloma (NDMM). Understanding the symptom burden …

Multiple myeloma is a disease of older adults, with a median age of 70 at diagnosis. Better
risk stratification strategies are required to identify older, fit adults who benefit from more …

The management of anticoagulation in patients with immune thrombocytopenia (ITP) is
challenging. This difficult clinical scenario is becoming increasingly common as the ITP …

… Contributors: Andrea Cervi and Amaris Balitsky contributed equally to the conceptual
design of the case summary and discussion topics. Both authors drafted, edited and critically …

Does the brain use a separate internal model for cursor mechanics during visuomotor
adaptation? We compared the amount of adaptation and transfer to the opposite arm when …

Patient‐reported outcome measures (PROMs), which are measures of symptom burden,
health‐related quality of life (HRQoL), and therapy effectiveness have become increasingly …

Objective. To compare health-related quality of life (HRQOL) of patients with antiphospholipid
syndrome (APS) and systemic lupus erythematosus (SLE) with and without previous …

Developing prognostic tools specifically for patients themselves represents an important
step in empowering patients to engage in shared decision-making. Incorporating patient-…

Background Clinically significant bleeding in patients with hematologic malignancies is a
heterogeneous composite outcome currently defined as World Health Organization (WHO) …

Background The role of maintenance therapy in transplant ineligible multiple myeloma (MM)
patients following a period of fixed duration induction therapy remains unclear. Objectives …